Enteric Disease Testing Market generated a revenue of USD 1,657 million in 2020 and is forecast to witness a CAGR of 6% during forecast period (2021-2028), owing to the ongoing technological advancements and strategic government support from the developing economies.

To have an edge over the competition by knowing the market dynamics and current trends of “Enteric Disease Testing Market”, request for Sample Report here

Market Dynamic 

Key Drivers and Emerging Trends

The rising incidences of food born diseases such as cholera, toxoplasmosis, etc. aided by the unhygienic food, improper drainage and sanitation systems and unsafe drinking water stands to be a major factor fueling the enteric disease testing market share. A substantial increase in the medical tourism, growing awareness about the benefits of early diagnosis, and the growing use of molecular diagnostics in various areas of microbiology, including strain identification and isolation of enteric pathogens are other factors projected to expand the market growth. Moreover, the growing emphasis of several international agencies, which includes the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), have initiated awareness programs and healthcare camps in different countries to promote the testing of enteric diseases, which will drive the market growth. In addition, various leading players are emphasizing on the commercialization of latest testing technologies is contributing to the market growth. However, inadequate awareness regarding enteric disease, high cost of equipment and lack of skilled laborers are projected to hamper the Enteric Disease Testing Market Size over the upcoming years.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

End Use – Segment Analysis

Food end-use industry is predicted to witness a higher CAGR over the forecast period. The growing emphasis of public health and government agencies to continuously ensure food quality in order to take the required actions to identify, contain, and correct sources of outbreaks, owing to the increasing international trade, stands to be a major factor fueling the segment’s growth. For example, the Enteric disease and Inspection Service enforced norms to manage the contamination of meat & poultry products in slaughterhouses and processing plants, depending on the HACCP enteric disease control system.

Technology – Segment Analysis

Rapid technology is estimated to hold a larger share over the forecast period, owing to their higher sensitivity, reliability, and faster results, thereby allowing producers to ensure safety and quality in their products.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

North America region is anticipated to lead the enteric disease Market over the upcoming years, owing to the increasing healthcare expenditure in the US and growing demand for healthy food. For example, as per the National Health Expenditure Accounts in 2019, U.S., the overall health care expenditure has increased to 4.6 percent in 2019 and reached to $3.8 trillion. Moreover, the increasing international trade has increased the incidences of typhoid fever in the U.S. For instance, nearly 500 people in the country were infected with the typhoid Salmonella virus annually. The region is home to various leading nations such as BD, Cepheid etc, which is another factor contributing to the regional growth.

Top Market Players 

Various notable players operating in the market, include, Cepheid., BD., Biomerica, Inc., Pro Lab Diagnostics Inc., Techlab, Inc., Coris BioConcept, Quest Diagnostics Incorporated., DiaSorin S.p.A., Trinity Biotech plc, BioMérieux SA, among others.

Key Developments:

• • In June 2021, SGS announced the opening of its new food testing laboratory in Papua New Guinea, which will offer internationally recognized quality testing to the hospitality, food manufacturing, and retail market segments.
  • In Feb 2021, Thermo Fisher Scientific, Inc. has acquired Mesa Biotech (US), which aims to expand the benefits of molecular diagnostics at hospitals.
  • In 2017, Meridian Bioscience decided to expand its business by launching Meridian Bioscience Beijing, LLC, a completely foreign owned enterprise (WFOE) in Beijing, China.

Segments covered in the Report:

The global Enteric Disease Testing Market has been segmented on the basis of End Use, Technology, and regions. Based on End Use, the market is segmented into Water and Food. Based on Technology, the market is segmented into Traditional, Rapid, Convenience-based, Polymerase chain reaction (PCR), Immunoassay and Chromatography & spectrometry.

For detailed scope of the “Enteric Disease Testing Market” report request a Sample Copy of the report 

Key questions answered in this research report:•

• • At what pace is global Enteric Disease Testing Market growing? What will be the growth trend in the future?
  •  What are the key drivers and restraints in Enteric Disease Testing Market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global Enteric Disease Testing Market?
  •  Which End Use generated maximum revenues in 2020 and identify the most promising End Use during the forecast period?
  •  What is the various Technology of global Enteric Disease Testing Market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation

Global Enteric Disease Testing Market by End Use

• • Water
  • Food

Global Enteric Disease Testing Market by Technology

• • Traditional
  • Rapid
  • Convenience-based
  • Polymerase chain reaction (PCR)
  • Immunoassay
  • Chromatography & spectrometry

Global Enteric Disease Testing Market by Region

• • North America Enteric Disease Testing Market (Option 1: As a part of the free 25% customization)
    • By End Use
    • By Technology
    • US Market All-Up
    • Canada Market All-Up
  • Europe Enteric Disease Testing Market (Option 2: As a part of the free 25% customization)
    • By End Use
    • By Technology
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Enteric Disease Testing Market (Option 3: As a part of the free 25% customization)
    • By End Use
    • By Technology
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Enteric Disease Testing Market (Option 4: As a part of the free 25% customization)
    • By End Use
    • By Technology
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Market Name (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Cepheid.
  •  BD.
  • Biomerica, Inc.
  • Pro Lab Diagnostics Inc.
  • Techlab, Inc.
  • Coris BioConcept
  • Quest Diagnostics Incorporated.
  • DiaSorin S.p.A.
  • Trinity Biotech plc
  • BioMérieux SA